Facebook Twitter LinkedIn Google Plus RSS

Amicus Therapeutics appoints new CMO, COO

By ,

Cranbury-based biopharmaceutical company Amicus Therapeutics Inc. announced Monday the appointment of Jay A. Barth as chief medical officer effective immediately.

According to the announcement, the company also announced the promotion of Bradley L. Campbell from chief business officer to chief operating officer, effective Dec. 2013.

Barth will be responsible for all clinical development activities as well as regulatory affairs.

Campbell will head several departments including business development, program management, commercial planning, patient and professional advocacy, and technical operations.  He will also oversee preclinical research and development, the announcement said.


Barnabas to launch its own health insurance plan

Five N.J. companies earn praise for working well with women-owned businesses

Mack-Cali announces major leadership shakeup

More From This Industry

Emily Bader

Emily Bader

Emily Bader is the Web Editor and Social Media Coordinator at NJBIZ. She is a Brielle, N.J. native and a Rutgers University alum. You can contact her at emilyb@njbiz.com.

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy